Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity
Linh T. Bui(University of Science and Technology - The University of Da Nang), Jonas C. Schupp(University Medical Center Freiburg), William Wallace(University of Edinburgh), Mei-I Chung(Translational Genomics Research Institute), Gísli Jenkins(Imperial College London), Doris M. Rassl(Papworth Hospital), Iván O. Rosas(Brigham and Women's Hospital), Chitra Joseph(University of Nottingham), Chase J. Taylor(Vanderbilt University Medical Center), Nichelle I. Winters(Vanderbilt University Medical Center), Sergio Poli(Brigham and Women's Hospital), Taylor Adams(Yale University), Jessica B. Blackburn(Vanderbilt University), Arun C. Habermann(Vanderbilt University Medical Center), Bradley W. Richmond(Vanderbilt University), Austin J. Gutierrez(Translational Genomics Research Institute), Naftali Kaminski(Yale University), Nicholas E. Banovich(Translational Genomics Research Institute), Andrew G. Nicholson(Guy's and St Thomas' NHS Foundation Trust), Jonathan A. Kropski(Vanderbilt University), Lance Peter(Translational Genomics Research Institute)
Cited by 9
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
Patterns of somatic mutation in human cancer genomes
|Nature|2007|3.1k